SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-003059
Filing Date
2018-04-25
Accepted
2018-04-25 16:59:37
Documents
1
Period of Report
2018-04-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formfour.html 4  
1 OWNERSHIP DOCUMENT formfour.xml 4 3316
  Complete submission text file 0001171843-18-003059.txt   4747
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM NC 27704
Business Address
Abbey Jeffrey D (Reporting) CIK: 0001543077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 18775017